Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 12:6:19.
doi: 10.3389/fmed.2019.00019. eCollection 2019.

Gut Microbiota and Chronic Constipation: A Review and Update

Toshifumi Ohkusa  1   2 , Shigeo Koido  2 , Yuriko Nishikawa  1 , Nobuhiro Sato  1
Affiliations
Review

Gut Microbiota and Chronic Constipation: A Review and Update

Toshifumi Ohkusa et al. Front Med (Lausanne). .

Abstract

Background: Chronic constipation, including functional constipation and constipation-type irritable bowel syndrome, is a prevalent, multifactorial gastrointestinal disorder, and its etiology and pathophysiology remain poorly understood. Recently studies using 16S rRNA-based microbiota profiling have demonstrated dysbiosis of gut microbiota in chronic constipation. Aims: To provide an overview of recent studies for microbiota in chronic constipation and treatments for chronic constipation using probiotics, prebiotics, synbiotics, antibiotics and fecal microbiota transplantation (FMT). Methods: PubMed searches were performed up to 1 August 2018 using keywords: "IBS," "IBS-C," "irritable bowel syndrome," "irritable bowel syndrome with constipation," "functional constipation," "chronic constipation" in combination with "gut microbiota," "dysbiosis," "gut microflora" for microbiota in chronic constipation, and in combination with "probiotics," "prebiotics," "synbiotics," "antibiotics," and "fecal microbiota transplantation." Results: The findings of gut microbiota in functional constipation are inconsistent, and currently no consensus exists. Although no clear consensus exists, compared with healthy subjects, IBS-C patients have a lower level of Actinobacteria, including Bifidobacteria, in their fecal samples and a higher level of Bacteroidetes in their mucosa. In most randomized controlled and parallel-group trials, probiotics, prebiotics, synbiotics, antibiotics, and FMT therapy for chronic constipation were effective with few side effects. However, there are many studies in a small number and the types of probiotics are different, it is difficult to evaluate the effect. Conclusions: Evidence indicates that dysbiosis of gut microbiota may contribute to functional constipation and constipation-type irritable bowel syndrome. Targeting treatments for the dysbiosis of constipation by probiotics, prebiotics, synbiotics, antibiotics, and FMT may be a new option, especially for refractory constipation to conventional therapies.

Keywords: FMT; antibiotics; chronic constipation; functional constipation; gut microbiota; irritable bowel syndrome with constipation; probiotics; synbiotics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Three broad categories of functional constipation.
Figure 2
Figure 2
Dysbiosis in IBS-C patient.
See this image and copyright information in PMC

References

    1. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. (2016) 375:2369–79. 10.1056/NEJMra1600266 - DOI - PubMed
    1. Yusof N, Hamid N, Ma ZF, Lawenko RM, Wan Mohammad WMZ, Collins DA, et al. . Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood. Gut Pathog. (2017) 9:75. 10.1186/s13099-017-0224-7 - DOI - PMC - PubMed
    1. Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, et al. . Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2013) 62:159–76. 10.1136/gutjnl-2012-302167 - DOI - PMC - PubMed
    1. Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E. The intestinal ecosystem in chronic functional constipation. Acta Paediatr. (1998) 87:836–41. 10.1111/j.1651-2227.1998.tb01547.x - DOI - PubMed
    1. Khalif IL, Quigley EM, Konovitch EA, Maximova ID. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig Liver Dis. (2005) 37:838–49. 10.1016/j.dld.2005.06.008 - DOI - PubMed